clinical trial Archive — Page 7 of 16

Salt shaker tipped over on a mound of spilled salt against a blue background.
November 13, 2023

Most can lower blood pressure by reducing salt, even those on BP drugs: study

New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake.

Blood clot simulation
November 10, 2023

Grant to advance prevention of hospital-acquired blood clots

A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.

Paul Newhouse, MD, smiling in a white medical coat with a stethoscope and striped tie in a hospital corridor.
October 25, 2023

Vanderbilt Center for Cognitive Medicine named Alzheimer’s Clinical Trials Consortium Member Site

The Vanderbilt Center for Cognitive Medicine has been named an Alzheimer’s Clinical Trials Consortium Member Site.

The research team includes, left to right, Bruno Scaglioni, PhD; Keith Obstein MD, MPH; James Martin, PhD; Claire Landewee, BS; Simone Calò, PhD; and Pietro Valdastri, PhD. (hoto by Susan Urmy)
October 17, 2023

VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies

A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.

Stylized polygonal human profile facing a network of connected hexagons containing healthcare symbols, including a cross, heart monitor, eye, syringe, pills, lungs, thermometer, stethoscope, laboratory flask, and hospital symbol, on a purple-to-blue digital background.
October 17, 2023

AI predicts blood clot risk in hospitalized children: VUMC study

An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.

Analog bathroom scale with a black textured platform and a round dial showing weight markings.
October 17, 2023

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.